Voreloxin (SNS-595)

Name: Voreloxin (SNS-595); MyBioSource
Brand: MyBioSource
SKU: MBS3602652
Price: 265 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3602652

A first-in-class anticancer quinolone derivative that intercalates DNA and inhibits Topoisomerase II. More details

$265 / 2 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Voreloxin, Biochemical

Full Product Name

Voreloxin

Product Synonym Names

SNS-595; Vosaroxin; AG 7352

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

401.4396

Suitability

10mM in DMSO

Target

Topoisomerase

Receptor

Topo II

Chemical Name

1, 8-Naphthyridine-3-carboxylic acid, 1, 4-dihydro-7-[(3S, 4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)

SMILES

O=C(C1=CN(C2=NC=CS2)C3=C(C=CC(N4C[C@H](OC)[C@@H](NC)C4)=N3)C1=O)O

Molecular Formula

C18H19N5O4S

CAS Number

175414-77-4

Product Categories/Family for Voreloxin biochemical

Chemotherapeutic; Cell Cycle/DNA Damage; Cancer

Product References and Citations for Voreloxin biochemical

1. Scatena CD, et al. Cancer Chemother Pharmacol. 2010 Oct; 66 (5):881-8.
2. Hoch U, et al. Cancer Chemother Pharmacol. 2009 Jun; 64 (1):53-65.
3. Walsby EJ, et al. Haematologica. 2011 Mar; 96 (3):393-9.

Other Notes

Small volumes of Voreloxin biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Voreloxin purchase

MBS3602652 is a biochemical targeting Voreloxin.